[1]
Le Guern AS, Martin L, Savin C, Carniel E. Yersiniosis in France: overview and potential sources of infection. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2016 May:46():1-7. doi: 10.1016/j.ijid.2016.03.008. Epub 2016 Mar 14
[PubMed PMID: 26987478]
Level 3 (low-level) evidence
[2]
Martínez-Chavarría LC, Vadyvaloo V. Yersinia pestis and Yersinia pseudotuberculosis infection: a regulatory RNA perspective. Frontiers in microbiology. 2015:6():956. doi: 10.3389/fmicb.2015.00956. Epub 2015 Sep 17
[PubMed PMID: 26441890]
Level 3 (low-level) evidence
[3]
Chouikha I, Hinnebusch BJ. Yersinia--flea interactions and the evolution of the arthropod-borne transmission route of plague. Current opinion in microbiology. 2012 Jun:15(3):239-46. doi: 10.1016/j.mib.2012.02.003. Epub 2012 Mar 7
[PubMed PMID: 22406208]
Level 3 (low-level) evidence
[4]
Santos-Montañez J, Benavides-Montaño JA, Hinz AK, Vadyvaloo V. Yersinia pseudotuberculosis IP32953 survives and replicates in trophozoites and persists in cysts of Acanthamoeba castellanii. FEMS microbiology letters. 2015 Jul:362(13):fnv091. doi: 10.1093/femsle/fnv091. Epub 2015 May 29
[PubMed PMID: 26025069]
Level 3 (low-level) evidence
[5]
Amphlett A. Far East Scarlet-Like Fever: A Review of the Epidemiology, Symptomatology, and Role of Superantigenic Toxin: Yersinia pseudotuberculosis-Derived Mitogen A. Open forum infectious diseases. 2016 Jan:3(1):ofv202. doi: 10.1093/ofid/ofv202. Epub 2015 Dec 17
[PubMed PMID: 26819960]
[6]
Rakin A, Schneider L, Podladchikova O. Hunger for iron: the alternative siderophore iron scavenging systems in highly virulent Yersinia. Frontiers in cellular and infection microbiology. 2012:2():151. doi: 10.3389/fcimb.2012.00151. Epub 2012 Nov 30
[PubMed PMID: 23226687]
[7]
Stanger KJ, McGregor H, Larsen J. Outbreaks of diarrhoea ('winter scours') in weaned Merino sheep in south-eastern Australia. Australian veterinary journal. 2018 May:96(5):176-183. doi: 10.1111/avj.12696. Epub
[PubMed PMID: 29691860]
[9]
Yang X, Pan J, Wang Y, Shen X. Type VI Secretion Systems Present New Insights on Pathogenic Yersinia. Frontiers in cellular and infection microbiology. 2018:8():260. doi: 10.3389/fcimb.2018.00260. Epub 2018 Jul 31
[PubMed PMID: 30109217]
[10]
Davis KM. All Yersinia Are Not Created Equal: Phenotypic Adaptation to Distinct Niches Within Mammalian Tissues. Frontiers in cellular and infection microbiology. 2018:8():261. doi: 10.3389/fcimb.2018.00261. Epub 2018 Aug 3
[PubMed PMID: 30128305]
[11]
Atkinson S, Williams P. Yersinia virulence factors - a sophisticated arsenal for combating host defences. F1000Research. 2016:5():. pii: F1000 Faculty Rev-1370. doi: 10.12688/f1000research.8466.1. Epub 2016 Jun 14
[PubMed PMID: 27347390]
[12]
Keto-Timonen R, Hietala N, Palonen E, Hakakorpi A, Lindström M, Korkeala H. Cold Shock Proteins: A Minireview with Special Emphasis on Csp-family of Enteropathogenic Yersinia. Frontiers in microbiology. 2016:7():1151. doi: 10.3389/fmicb.2016.01151. Epub 2016 Jul 22
[PubMed PMID: 27499753]
[13]
Chauhan N, Wrobel A, Skurnik M, Leo JC. Yersinia adhesins: An arsenal for infection. Proteomics. Clinical applications. 2016 Oct:10(9-10):949-963. doi: 10.1002/prca.201600012. Epub 2016 May 17
[PubMed PMID: 27068449]
[14]
Woodman I, Schofield JB, Haboubi N. The histopathological mimics of inflammatory bowel disease: a critical appraisal. Techniques in coloproctology. 2015 Dec:19(12):717-27. doi: 10.1007/s10151-015-1372-8. Epub 2015 Sep 18
[PubMed PMID: 26385573]
[15]
May AN, Piper SM, Boutlis CS. Yersinia intussusception: case report and review. Journal of paediatrics and child health. 2014 Feb:50(2):91-5. doi: 10.1111/jpc.12240. Epub 2013 May 28
[PubMed PMID: 23711231]
Level 3 (low-level) evidence
[16]
Lemaitre BC, Mazigh DA, Scavizzi MR. Failure of beta-lactam antibiotics and marked efficacy of fluoroquinolones in treatment of murine Yersinia pseudotuberculosis infection. Antimicrobial agents and chemotherapy. 1991 Sep:35(9):1785-90
[PubMed PMID: 1952849]
[17]
Zaĭtseva EA, Shubin FN, Besednova NN. [Yersinia pseudotuberculosis sensitivity to fluoroquinolones and the efficacy of pefloxacin in experimental pseudotuberculosis]. Zhurnal mikrobiologii, epidemiologii i immunobiologii. 1997 Sep-Oct:(5):49-52
[PubMed PMID: 9432847]
[18]
Zaĭtseva EA, Shubin FN, Besednova NN. [Comparative study of the antimicrobial activity of pefloxacin, ciprofloxacin, norfloxacin and azithromycin with respect to Strains of Yersinia pseudotuberculosis]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 1996 Jan:41(1):19-21
[PubMed PMID: 8762820]
Level 2 (mid-level) evidence
[19]
Cormier G, Lucas V, Varin S, Hamelin JP, Tanguy G. Yersinia pseudotuberculosis infection of a lumbar facet joint. Joint bone spine. 2007 Jan:74(1):110-1
[PubMed PMID: 17197222]
[20]
Rathmell WK, Arguin P, Chan S, Yu A. Yersinia pseudotuberculosis bacteremia and splenic abscess in a patient with non-insulin-dependent diabetes mellitus. The Western journal of medicine. 1999 Feb:170(2):110-2
[PubMed PMID: 10063398]
[21]
Hadou T, Elfarra M, Alauzet C, Guinet F, Lozniewski A, Lion C. Abdominal aortic aneurysm infected by Yersinia pseudotuberculosis. Journal of clinical microbiology. 2006 Sep:44(9):3457-8
[PubMed PMID: 16954300]
[22]
Kimura J, Sasaki K. Yersinia pseudotuberculosis infection intractable by antibiotics: A rare case report. International journal of surgery case reports. 2016:21():139-41. doi: 10.1016/j.ijscr.2016.02.039. Epub 2016 Mar 4
[PubMed PMID: 27002288]
Level 3 (low-level) evidence
[23]
Srinivasa KG, Vidhya JV, Manohar TM, Naik M. Right Hemicolectomy for Intestinal Obstruction Due to Yersinia pseudotuberculosis: A Histopathological Surprise. The Indian journal of surgery. 2013 Jun:75(Suppl 1):214-6. doi: 10.1007/s12262-012-0580-y. Epub 2012 Jul 4
[PubMed PMID: 24426569]
[24]
Ansong C, Schrimpe-Rutledge AC, Mitchell HD, Chauhan S, Jones MB, Kim YM, McAteer K, Deatherage Kaiser BL, Dubois JL, Brewer HM, Frank BC, McDermott JE, Metz TO, Peterson SN, Smith RD, Motin VL, Adkins JN. A multi-omic systems approach to elucidating Yersinia virulence mechanisms. Molecular bioSystems. 2013 Jan 27:9(1):44-54. doi: 10.1039/c2mb25287b. Epub 2012 Nov 13
[PubMed PMID: 23147219]
[25]
Naktin J, Beavis KG. Yersinia enterocolitica and Yersinia pseudotuberculosis. Clinics in laboratory medicine. 1999 Sep:19(3):523-36, vi
[PubMed PMID: 10549424]
[26]
Hannu T, Mattila L, Nuorti JP, Ruutu P, Mikkola J, Siitonen A, Leirisalo-Repo M. Reactive arthritis after an outbreak of Yersinia pseudotuberculosis serotype O:3 infection. Annals of the rheumatic diseases. 2003 Sep:62(9):866-9
[PubMed PMID: 12922960]
[27]
Kaasch AJ, Dinter J, Goeser T, Plum G, Seifert H. Yersinia pseudotuberculosis bloodstream infection and septic arthritis: case report and review of the literature. Infection. 2012 Apr:40(2):185-90. doi: 10.1007/s15010-011-0160-2. Epub 2011 Jul 26
[PubMed PMID: 21789525]
Level 3 (low-level) evidence
[28]
Larkin DF, Cafferkey MT, Eustace P. Yersinia-induced uveitis in Ireland. The British journal of ophthalmology. 1988 Dec:72(12):938-41
[PubMed PMID: 3228549]
[29]
Fukumoto Y, Hiraoka M, Takano T, Hori C, Tsuchida S, Kikawa Y, Sudo M. Acute tubulointerstitial nephritis in association with Yersinia pseudotuberculosis infection. Pediatric nephrology (Berlin, Germany). 1995 Feb:9(1):78-80
[PubMed PMID: 7742229]
[30]
Iijima K, Yoshikawa N, Sato K, Matsuo T. Acute interstitial nephritis associated with Yersinia pseudotuberculosis infection. American journal of nephrology. 1989:9(3):236-40
[PubMed PMID: 2667363]